Nuveen Asset Management, LLC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 210 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2016. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$191,083
-53.7%
56,2010.0%0.00%
Q2 2023$413,077
+28969.5%
56,201
-59.0%
0.00%
-100.0%
Q1 2023$1,421
-19.1%
137,195
-7.7%
0.00%0.0%
Q4 2022$1,757
-100.0%
148,701
-21.3%
0.00%0.0%
Q3 2022$3,589,000
-33.2%
188,876
+9.2%
0.00%
-50.0%
Q2 2022$5,371,000
-27.0%
173,040
-16.4%
0.00%0.0%
Q1 2022$7,359,000
-13.7%
207,007
+5.5%
0.00%
-33.3%
Q4 2021$8,529,000
-19.4%
196,204
-24.3%
0.00%0.0%
Q3 2021$10,588,000
-48.4%
259,038
-20.5%
0.00%
-50.0%
Q2 2021$20,532,000
-45.7%
325,959
-28.0%
0.01%
-50.0%
Q1 2021$37,817,000
+15.5%
452,784
+23.9%
0.01%
+9.1%
Q4 2020$32,739,000
+1.8%
365,390
+17.4%
0.01%
-8.3%
Q3 2020$32,167,000
+43.5%
311,303
+9.8%
0.01%
+33.3%
Q2 2020$22,418,000
+45.2%
283,482
+6.3%
0.01%
+12.5%
Q1 2020$15,437,000
+21.6%
266,796
+13.4%
0.01%
+60.0%
Q4 2019$12,696,000
+29.6%
235,315
+25.6%
0.01%
+25.0%
Q3 2019$9,797,000
+1.0%
187,403
-6.7%
0.00%0.0%
Q2 2019$9,704,000
+523.2%
200,846
+551.5%
0.00%
-50.0%
Q1 2019$1,557,000
+8.2%
30,828
+27.0%
0.01%
-11.1%
Q4 2018$1,439,000
-38.9%
24,283
-32.2%
0.01%
-30.8%
Q3 2018$2,357,000
-16.0%
35,799
-35.6%
0.01%
-27.8%
Q2 2018$2,807,000
+1.6%
55,601
+6.0%
0.02%0.0%
Q1 2018$2,763,000
+26.3%
52,476
+11.4%
0.02%
+28.6%
Q4 2017$2,188,000
-2.5%
47,089
-15.1%
0.01%
-6.7%
Q3 2017$2,243,000
-7.5%
55,454
-22.4%
0.02%
-6.2%
Q2 2017$2,424,000
+30.0%
71,473
+11.4%
0.02%
+45.5%
Q1 2017$1,864,000
-5.0%
64,187
+7.4%
0.01%
+10.0%
Q4 2016$1,962,000
+0.1%
59,747
-3.9%
0.01%
-9.1%
Q3 2016$1,960,000
+18.2%
62,148
+5.4%
0.01%
+10.0%
Q2 2016$1,658,000
-24.8%
58,959
-2.8%
0.01%
-16.7%
Q1 2016$2,206,000
-4.8%
60,685
+4.8%
0.01%0.0%
Q4 2015$2,317,000
+64.9%
57,900
+17.4%
0.01%
+50.0%
Q3 2015$1,405,000
+106.6%
49,314
+139.0%
0.01%
+100.0%
Q2 2015$680,00020,6330.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Zebra Capital Management LLC 25,250$784,0002.30%
Global Alpha Capital Management Ltd. 418,030$12,976,0001.40%
AIMZ Investment Advisors, LLC 70,588$2,191,0001.05%
PALISADE CAPITAL MANAGEMENT, LP 566,080$17,571,0000.48%
RICE HALL JAMES & ASSOCIATES, LLC 261,533$8,118,0000.39%
EARNEST PARTNERS LLC 1,844,621$57,257,0000.38%
SummerHaven Investment Management, LLC 14,476$449,0000.30%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,085,874$33,706,0000.26%
Ridgewood Investments LLC 10,004$311,0000.24%
DUALITY ADVISERS, LP 65,650$2,038,0000.20%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders